Heparin-Induced Thrombocytopenia, Fourth Edition : Abridged, Special Edition

Popular Articles

• PolyMedic, Inc. (OTCBB: PYMX) $85M (MarketCap) Successfully Completes Phase 1B Clinical Study
• Primary pulmonary hypertension symptoms
• Early Intervention Is Indicated For Treatment of DVT
• Causes, Symptoms, Diagnosis, Prognosis And Latest Treatment For Atrial Fibrillation
• Vitamin K Reduces the Risk for Non-Hodgkin Lymphoma